Cell line · CVCL_6926
Papers36
1 to 20 of 36
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Genetically engineered RNA inducers of proximity for protein regulation. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Phytochemical Analysis and Biological Activities of Essential Oils from Leaves and Stems of Dicranopteris pedata (Houtt.) Nakaike. | Molecules | 2026 | Its Methods give the RRID and name the line | PubMed | |
| RNF180 loss stabilizes BCAS4 to enhance PD-L1 expression and immune evasion in hepatocellular carcinoma. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting Cuproptosis and Ferroptosis via a ROS-Responsive Nanoplatform for Enhanced Synergistic Therapy Against Hepatocellular Carcinoma. | Antioxidants (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Ultra-Radiostable Covalent Conformationally Interlocked Networks Enabling a Universal Radiometal-Labeling Platform for Cancer Radioembolization. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| CENPA as a Genome Stability-Associated Biomarker in Hepatocellular Carcinoma: Multiomics Analysis and Experimental Validation. | Hum Mutat | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Glycolysis-dependent reactive oxygen species mediate desmopressin acetate-induced rescue of platelet dysfunction caused by antiplatelet therapy. | Med Gas Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| pH-responsive selenium nanoplatform for targeted drug release and immune remodeling in microbiota-associated colorectal cancer. | J Nanobiotechnology | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Src-mediated PHB2 phosphorylation disrupts mitochondrial cristae through cardiolipin dissociation in hepatocellular carcinoma. | Redox Biol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The rs713586 risk variant dysregulates ADCY3 rather than DNAJC27, leading to obesity through ZFP42-TET1-mediated DNA methylation. | EBioMedicine | 2026 | Its Methods give the RRID and name the line | PubMed | |
| LMNB2-mediated high PD-L1 transcription triggers the immune escape of hepatocellular carcinoma. | Cell Death Discov | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Licorice attenuates cisplatin-induced hepatotoxicity by alleviating endoplasmic reticulum stress and apoptosis. | Front Pharmacol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Succinate supplementation alleviates liver cancer by inhibiting the FN1/SQLE axis-mediated cholesterol biosynthesis. | iScience | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Prognostic, oncogenic roles, and pharmacogenomic features of AMD1 in hepatocellular carcinoma. | Cancer Cell Int | 2024 | Its Methods give the RRID and name the line | PubMed | |
| SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion. | Oncoimmunology | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Design, synthesis and biological evaluation of novel podophyllotoxin derivatives as tubulin-targeting anticancer agents. | Pharm Biol | 2024 | Its Methods give the RRID and name the line | PubMed | |
| NIR-II fluorescence-guided liver cancer surgery by a small molecular HDAC6 targeting probe. | EBioMedicine | 2023 | Its Methods give the RRID and name the line | PubMed | |
| The Role of miR-1183: A Potential Suppressor in Hepatocellular Carcinoma via Regulating Splicing Factor SRSF1. | J Hepatocell Carcinoma | 2023 | Its Methods give the RRID and name the line | PubMed | |
| An HBV susceptibility variant of KNG1 modulates the therapeutic effects of interferons α and λ1 in HBV infection by promoting MAVS lysosomal degradation. | EBioMedicine | 2023 | Its Methods give the RRID and name the line | PubMed | |
| High glucose-induced glucagon resistance and membrane distribution of GCGR revealed by super-resolution imaging. | iScience | 2023 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_6926/papers